In lymphocytes, the TEC family tyrosine-kinase proteins BTK (bruton tyrosine kinase), ITK (IL2 inducible T-cell kinase), and TEC are PI3K effectors that are activated by PIP3, with potential anti-tumor therapeutic implications. This evidence concerns the gene PIK3CD and neoplasm.